COVID-19
As the largest ransomware attack in the history of the US healthcare sector continues to have far-reaching consequences, the industry has been forced to confront the harsh realities of data breaches. Karly Rowe, SVP of Product Management at Inovalon, highlights the significance of this event, emphasizing that healthcare records are
COVID-19
Research from Japan sheds light on the vulnerability of long-term care facilities (LTCFs) to COVID-19, even during the Omicron outbreak. A study conducted in a 450-bed LTCF found that mortality was lower in the infected group than in the uninfected group, and infection was not significantly associated with increased mortality.
COVID-19
Researchers from the All India Institute of Medical Sciences (AIIMS) have published a study in the journal Viruses that sheds light on the transmission dynamics of COVID-19. The investigation finds that respiratory droplets are the primary mode of transmission for the SARS-CoV-2 virus, which enters host cells through ACE2 receptors,
COVID-19
The World Health Organization recommends periodic evaluation of influenza surveillance systems to assess their performance, identify shortfalls, and provide evidence for policymaking and public health interventions. However, research from the Ethiopian Public Health Institute found that the existing surveillance system in Ethiopia lacks data on the performance of the system
COVID-19
Researchers from the University of Milan have made significant strides in the development of a novel series of indole-based ethyl cinnamate derivatives that have shown promising results in inhibiting the SARS-CoV-2 Main Protease (M) and human cathepsins, essential enzymes involved in viral replication and entry. These findings suggest that these
COVID-19
In an effort to prevent complications from COVID-19, 30 prominent professional health organizations, including the American College of Obstetricians and Gynecologists (ACOG), have signed an open letter to insurers urging them to continue covering vaccinations during pregnancy. The letter, released this week, emphasizes the safety and efficacy of COVID-19 vaccinations
COVID-19
Sri Lanka is facing a severe public health emergency due to the widespread outbreak of dengue and the resurgence of the chikungunya virus. The country's tropical climate and rapid urbanisation have created an ideal environment for mosquito-borne diseases to thrive. According to Dr. Preshila Samaraweera, a consultant community
COVID-19
Researchers at Boston University have published a study examining the effectiveness of COVID-19 vaccinations in individuals with a history of SARS-CoV-2 infection. The study aimed to clarify the durability of anti-viral antibody responses, which is crucial for epidemiological applications. The investigators utilized the BU ELISA protocol to measure circulating SARS-CoV-2
COVID-19
Results from the initial cohort of Novavax's COVID-19-Influenza Combination and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza vaccine candidates have shown both vaccines induced robust immune responses and were well tolerated in adults aged 65 and older. The Phase 3 trial was designed to provide descriptive data on three
COVID-19
A new study analyzing data from the EudraVigilance database has shed light on the safety profile of COVID-19 vaccines. Conducted by researchers from the Medical University of Gdansk, the retrospective observational study examined 250,966 suspected serious adverse reactions (SADRs) following the administration of 733,837,251 vaccine doses against
COVID-19
Efforts to combat the COVID-19 pandemic have led to the implementation of electronic case-based disease surveillance (eCBDS) in Sierra Leone. According to a new study, the country has seen significant improvements in data collection and disease tracking, but more work is needed to ensure widespread adoption. The World Health Organization
COVID-19
South African Health Minister Aaron Motsoaledi briefed the G20 Health Working Group on the emergence of a new Covid-19 variant, Nimbus or NB.1.8.1, which shares a lineage with Omicron but is not considered a cause for concern due to the effectiveness of current vaccines. The variant is
